Ferrari N.V. Announces Dividend Distribution Proposal Of €1.810/Share, Implying An Increase Of 33% YoY; Subject To Approval By The Annual General Meeting Of Shareholders April 14, 2023
Ferrari N.V. (NYSE/EXM: RACE) (the "Company") announced today that its Board of Directors intends to recommend to the Company's shareholders a dividend distribution to the holders of common shares of Euro
American Airlines Names Ex-Boeing Finance Chief As Chairman
American Airlines Group Inc (NASDAQ:AAL) has named Greg Smith as independent chairman of the company’s board of directors, effective April 30,…
Intuit Announces CFO Succession Plan; Sandeep Singh Aujla To Become CFO; Michelle Clatterbuck Announces Plans To Retire
Sandeep Singh Aujla to Become CFO; Michelle Clatterbuck Announces Plans to Retire
Intuit Inc. (NASDAQ:INTU), the global financial technology platform that makes TurboTax, Credit Karma, QuickBooks,
SPAR Group, Inc. Names Antonio Calisto Pato As Chief Financial Officer Effective February 27
SPAR Group, Inc. (NASDAQ: SGRP) ("SPAR Group" and the "Corporation", and together with its subsidiaries the "Company"), a leading global provider of services to retail and
Impel Pharmaceuticals Earlier Announced Streamlining Plan, Including 16% Workforce Reduction, Largely In The R&D Functions, The Company Plans To Reprioritize Spending On Trudhesa (Dihydroergotamine Mesylate) Nasal Spray For Migraine
The plan will halt research and development efforts on INP105 (olanzapine) to address acute agitation and aggression in autism spectrum disorder.
Aligned with this, the Company also announced that Stephen
Reported Late Wednesday Feb 22, Norfolk Southern Announces It Will Now Excavate The Soil And Replace The Tracks In The Derailment Area As Part Of An Enhanced Remediation Plan
Norfolk Southern Corporation (NYSE:NSC) announced that it will now excavate the soil and replace the tracks in the derailment area as part of an enhanced remediation plan. The change comes in response to feedback from
Awakn’s First Licensing Partnership Deal In Europe Involves Chain Of Portuguese Clinics
Awakn Life Sciences Corp. (OTCQB: AWKNF) has signed a licensing partnership agreement in Europe with a Portugal-based healthcare consortium currently operating in stealth mode.